Copyright
©The Author(s) 2022.
World J Gastrointest Surg. Apr 27, 2022; 14(4): 276-285
Published online Apr 27, 2022. doi: 10.4240/wjgs.v14.i4.276
Published online Apr 27, 2022. doi: 10.4240/wjgs.v14.i4.276
Study title | Resection of metastatic PNETs after induction system treatment | Single-cell sequencing and establishment of models in NEN | Endoscopic ultrasound-guided radiofrequency ablation for the treatment | Prophylactic cholecystectomy in midgut NET patients who require primary tumor surgery |
Primary site | Pancreas | GEP NEN | Pancreas | Jejunum, ileum, proximal colon |
Study type | Observational | Observational | Interventional | Interventional |
Multicentric | No | No | Yes | Yes |
Primary purpose | NA | NA | Treatment | Treatment |
Allocation | NA | NA | NA | Randomized |
Estimated enrollment | 180 participants | 200 participants | 70 participants | 100 participants |
Estimated study completion date | July 25, 2025 | December 2022 | June 1, 2021 | April 2025 |
- Citation: Stankiewicz R, Grąt M. Current status of surgical management of patients with gastroenteropancreatic neuroendocrine neoplasms. World J Gastrointest Surg 2022; 14(4): 276-285
- URL: https://www.wjgnet.com/1948-9366/full/v14/i4/276.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i4.276